Franklin Resources’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
JT
PA
BBA
OAG
Franklin Resources's PRAX Position: Q2 2026 in Review
Franklin Resources increased its Praxis Precision Medicines (PRAX) stake by 18% in Q2 2026, buying an estimated $16.1M and bringing the position to 327,124 shares worth $110M. The position accounts for 0.02% of the portfolio, ranked #438.
Franklin Resources first reported a position in PRAX in Q4 2020 and has held it in 16 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Franklin Resources held 327,124 shares of Praxis Precision Medicines worth $110M as of Q2 2026.
- Franklin Resources bought 51,001 Praxis Precision Medicines shares in Q2 2026, an estimated $16.1M.
- Praxis Precision Medicines made up 0.02% of Franklin Resources's portfolio in Q2 2026, its #438 holding.
- Franklin Resources first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 16 quarters since.
- 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.